Both in Pharmaceuticals
Dianthus Therapeutics vs Arcutis Biotherapeutics
Over the past year DNTH returned +158.5% and ARQT returned +41.8%; their daily moves had a correlation of 0.36.
DNTH +158.5% ARQT +41.8%Growth of $1, one year, split-adjusted
| Metric | DNTH | ARQT |
|---|---|---|
| Price | $85.81 | $34.05 |
| Market cap | $4.80B | $4.28B |
| Today | +3.76% | +6.41% |
| 1 month | +0.5% | +42.3% |
| 6 months | −5.1% | +40.9% |
| Year to date | +108.2% | +17.3% |
| 1 year | +152.2% | +37.5% |
| Revenue growth (YoY) | +294.3% | +59.3% |
| Gross margin | 100.0% | 91.6% |
| Net margin | −6598.6% | 11.6% |
| P/E (TTM) | — | 150.1× |
| Price / sales | 2,520.9× | 9.2× |
| Net cash | $886.8M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 54.8% |
| Short % of float | 18.4% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).